Radiation therapy for older patients with brain tumors

Giuseppe Minniti, Andrea Riccardo Filippi, Mattia Falchetto Osti, Umberto Ricardi

Research output: Contribution to journalReview article

Abstract

The incidence of brain tumors in the elderly population has increased over the last few decades. Current treatment includes surgery, radiotherapy and chemotherapy, but the optimal management of older patients with brain tumors remains a matter of debate, since aggressive radiation treatments in this population may be associated with high risks of neurological toxicity and deterioration of quality of life. For such patients, a careful clinical status assessment is mandatory both for clinical decision making and for designing randomized trials to adequately evaluate the optimal combination of radiotherapy and chemotherapy. Several randomized studies have demonstrated the efficacy and safety of chemotherapy for patients with glioblastoma or lymphoma; however, the use of radiotherapy given in association with chemotherapy or as salvage therapy remains an effective treatment option associated with survival benefit. Stereotactic techniques are increasingly used for the treatment of patients with brain metastases and benign tumors, including pituitary adenomas, meningiomas and acoustic neuromas. Although no randomized trials have proven the superiority of SRS over other radiation techniques in older patients with brain metastases or benign brain tumors, data extracted from recent randomized studies and large retrospective series suggest that SRS is an effective approach in such patients associated with survival advantages and toxicity profile similar to those observed in young adults. Future trials need to investigate the optimal radiation techniques and dose/fractionation schedules in older patients with brain tumors with regard to clinical outcomes, neurocognitive function, and quality of life.

Original languageEnglish
Article number101
JournalRadiation Oncology
Volume12
Issue number1
DOIs
Publication statusPublished - Jun 19 2017

Fingerprint

Brain Neoplasms
Radiotherapy
Radiation
Drug Therapy
Stereotaxic Techniques
Quality of Life
Dose Fractionation
Neoplasm Metastasis
Salvage Therapy
Acoustic Neuroma
Survival
Brain
Pituitary Neoplasms
Meningioma
Therapeutics
Glioblastoma
Patient Safety
Combination Drug Therapy
Population
Young Adult

Keywords

  • Brain tumors
  • Chemotherapy
  • Elderly
  • Radiosurgery
  • Radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Minniti, G., Filippi, A. R., Osti, M. F., & Ricardi, U. (2017). Radiation therapy for older patients with brain tumors. Radiation Oncology, 12(1), [101]. https://doi.org/10.1186/s13014-017-0841-9

Radiation therapy for older patients with brain tumors. / Minniti, Giuseppe; Filippi, Andrea Riccardo; Osti, Mattia Falchetto; Ricardi, Umberto.

In: Radiation Oncology, Vol. 12, No. 1, 101, 19.06.2017.

Research output: Contribution to journalReview article

Minniti, G, Filippi, AR, Osti, MF & Ricardi, U 2017, 'Radiation therapy for older patients with brain tumors', Radiation Oncology, vol. 12, no. 1, 101. https://doi.org/10.1186/s13014-017-0841-9
Minniti, Giuseppe ; Filippi, Andrea Riccardo ; Osti, Mattia Falchetto ; Ricardi, Umberto. / Radiation therapy for older patients with brain tumors. In: Radiation Oncology. 2017 ; Vol. 12, No. 1.
@article{6c1fc5481b80432f9c3dc5196cf8c420,
title = "Radiation therapy for older patients with brain tumors",
abstract = "The incidence of brain tumors in the elderly population has increased over the last few decades. Current treatment includes surgery, radiotherapy and chemotherapy, but the optimal management of older patients with brain tumors remains a matter of debate, since aggressive radiation treatments in this population may be associated with high risks of neurological toxicity and deterioration of quality of life. For such patients, a careful clinical status assessment is mandatory both for clinical decision making and for designing randomized trials to adequately evaluate the optimal combination of radiotherapy and chemotherapy. Several randomized studies have demonstrated the efficacy and safety of chemotherapy for patients with glioblastoma or lymphoma; however, the use of radiotherapy given in association with chemotherapy or as salvage therapy remains an effective treatment option associated with survival benefit. Stereotactic techniques are increasingly used for the treatment of patients with brain metastases and benign tumors, including pituitary adenomas, meningiomas and acoustic neuromas. Although no randomized trials have proven the superiority of SRS over other radiation techniques in older patients with brain metastases or benign brain tumors, data extracted from recent randomized studies and large retrospective series suggest that SRS is an effective approach in such patients associated with survival advantages and toxicity profile similar to those observed in young adults. Future trials need to investigate the optimal radiation techniques and dose/fractionation schedules in older patients with brain tumors with regard to clinical outcomes, neurocognitive function, and quality of life.",
keywords = "Brain tumors, Chemotherapy, Elderly, Radiosurgery, Radiotherapy",
author = "Giuseppe Minniti and Filippi, {Andrea Riccardo} and Osti, {Mattia Falchetto} and Umberto Ricardi",
year = "2017",
month = "6",
day = "19",
doi = "10.1186/s13014-017-0841-9",
language = "English",
volume = "12",
journal = "Radiation Oncology",
issn = "1748-717X",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Radiation therapy for older patients with brain tumors

AU - Minniti, Giuseppe

AU - Filippi, Andrea Riccardo

AU - Osti, Mattia Falchetto

AU - Ricardi, Umberto

PY - 2017/6/19

Y1 - 2017/6/19

N2 - The incidence of brain tumors in the elderly population has increased over the last few decades. Current treatment includes surgery, radiotherapy and chemotherapy, but the optimal management of older patients with brain tumors remains a matter of debate, since aggressive radiation treatments in this population may be associated with high risks of neurological toxicity and deterioration of quality of life. For such patients, a careful clinical status assessment is mandatory both for clinical decision making and for designing randomized trials to adequately evaluate the optimal combination of radiotherapy and chemotherapy. Several randomized studies have demonstrated the efficacy and safety of chemotherapy for patients with glioblastoma or lymphoma; however, the use of radiotherapy given in association with chemotherapy or as salvage therapy remains an effective treatment option associated with survival benefit. Stereotactic techniques are increasingly used for the treatment of patients with brain metastases and benign tumors, including pituitary adenomas, meningiomas and acoustic neuromas. Although no randomized trials have proven the superiority of SRS over other radiation techniques in older patients with brain metastases or benign brain tumors, data extracted from recent randomized studies and large retrospective series suggest that SRS is an effective approach in such patients associated with survival advantages and toxicity profile similar to those observed in young adults. Future trials need to investigate the optimal radiation techniques and dose/fractionation schedules in older patients with brain tumors with regard to clinical outcomes, neurocognitive function, and quality of life.

AB - The incidence of brain tumors in the elderly population has increased over the last few decades. Current treatment includes surgery, radiotherapy and chemotherapy, but the optimal management of older patients with brain tumors remains a matter of debate, since aggressive radiation treatments in this population may be associated with high risks of neurological toxicity and deterioration of quality of life. For such patients, a careful clinical status assessment is mandatory both for clinical decision making and for designing randomized trials to adequately evaluate the optimal combination of radiotherapy and chemotherapy. Several randomized studies have demonstrated the efficacy and safety of chemotherapy for patients with glioblastoma or lymphoma; however, the use of radiotherapy given in association with chemotherapy or as salvage therapy remains an effective treatment option associated with survival benefit. Stereotactic techniques are increasingly used for the treatment of patients with brain metastases and benign tumors, including pituitary adenomas, meningiomas and acoustic neuromas. Although no randomized trials have proven the superiority of SRS over other radiation techniques in older patients with brain metastases or benign brain tumors, data extracted from recent randomized studies and large retrospective series suggest that SRS is an effective approach in such patients associated with survival advantages and toxicity profile similar to those observed in young adults. Future trials need to investigate the optimal radiation techniques and dose/fractionation schedules in older patients with brain tumors with regard to clinical outcomes, neurocognitive function, and quality of life.

KW - Brain tumors

KW - Chemotherapy

KW - Elderly

KW - Radiosurgery

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=85020917580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020917580&partnerID=8YFLogxK

U2 - 10.1186/s13014-017-0841-9

DO - 10.1186/s13014-017-0841-9

M3 - Review article

AN - SCOPUS:85020917580

VL - 12

JO - Radiation Oncology

JF - Radiation Oncology

SN - 1748-717X

IS - 1

M1 - 101

ER -